Orris

All psychiatric drugs are H1 ?

Reading File
Finding Sources
Finding Sources
No. Not all psychiatric drugs are H1 (histamine-1) receptor antagonists. Only a subset of psychiatric drugs bind and block H1 receptors, and this is a side property, not what defines them as "psychiatric" drugs.
Which psychiatric drugs DO have significant H1 antagonism:
  • Many antipsychotics (especially low-potency first-generation agents like chlorpromazine, and second-generation agents like olanzapine, quetiapine, clozapine) - H1 blockade here contributes to sedation and weight gain (Kaplan & Sadock's Synopsis of Psychiatry, Table 33-2; Goodman & Gilman's Pharmacological Basis of Therapeutics, p. ~2729).
  • Some antidepressants, particularly tricyclics (TCAs) - doxepin is the most potent H1 blocker among TCAs, and mirtazapine is even more potent, which is why both cause sedation/weight gain and low-dose doxepin is actually used as a hypnotic (Stahl's Essential Psychopharmacology; Kaplan & Sadock's Comprehensive Textbook of Psychiatry, "Central Nervous System" section).
Which psychiatric drugs generally do NOT act meaningfully through H1:
  • SSRIs (fluoxetine, sertraline, escitalopram, etc.) - act on serotonin transporters
  • SNRIs (venlafaxine, duloxetine)
  • MAOIs
  • Lithium
  • Most benzodiazepines - act via GABA-A receptors
  • Stimulants (methylphenidate, amphetamines) - act via dopamine/norepinephrine reuptake
  • Many newer/high-potency antipsychotics (e.g., haloperidol, aripiprazole) have relatively low H1 affinity compared to D2, 5-HT2A, or partial dopamine agonism, which are their primary mechanisms
Why this matters clinically: H1 receptor antagonism in psychiatric drugs is mainly responsible for sedation and weight gain as side effects, not the therapeutic (antipsychotic/antidepressant) action itself - it's "unclear whether this property plays a role in the antipsychotic effects of these agents" (Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 1660-1663). The core therapeutic mechanisms of psychiatric drugs are far more varied, involving dopamine, serotonin, norepinephrine, GABA, glutamate, and other systems depending on the drug class.
So the correct framing is: some psychiatric drugs have clinically relevant H1 antagonism as a side-effect mechanism, but this is far from universal across psychiatric drug classes.

What are the H1 drugs in psychiatry

Finding Sources
Finding Sources

H1 (Histamine-1) Receptor Drugs Used in Psychiatry

H1 antagonism shows up across several psychiatric drug classes - sometimes as the main sedating/anxiolytic mechanism, sometimes as an unwanted side effect of a drug whose real target is dopamine or serotonin.

1. Antipsychotics (H1 blockade drives sedation/weight gain)

Relative H1 affinity varies a lot by agent. From Katzung's Basic and Clinical Pharmacology's receptor-affinity ranking:
  • Quetiapine: H1 > α1 (H1 is actually its highest affinity target)
  • Olanzapine: 5-HT2A > H1 > D4 > D2 > α1 > D1 (strong H1 affinity)
  • Clozapine: high H1 affinity, contributes to marked sedation
  • Chlorpromazine (low-potency FGA): high H1 affinity, classic sedating antipsychotic
  • Haloperidol: D2 > α1 > D4 > 5-HT2A > D1 > H1 (H1 affinity is low/last)
  • Aripiprazole: α1 = H1, low relative to D2/5-HT2A
  • Ziprasidone: notably poor H1 affinity - one reason it has low weight-gain risk
General rule (Goodman & Gilman's, Katzung's): sedating antipsychotics = low-potency FGAs (chlorpromazine) and the SGAs clozapine, olanzapine, quetiapine - all high-H1-affinity drugs. High-potency FGAs (haloperidol) and low-H1 SGAs (ziprasidone, aripiprazole, lurasidone) cause much less sedation and less H1-driven weight gain.

2. Antidepressants

  • Mirtazapine - very high H1 affinity, actually more potent than doxepin at H1; this is the main reason it's sedating and used at low doses for sleep/appetite stimulation
  • Doxepin - the most potent H1 blocker among the tricyclic antidepressants; at very low doses (3-6 mg) it's FDA-approved purely as a hypnotic (Silenor) via H1 blockade, well below the dose needed for antidepressant (serotonin/norepinephrine) effects
  • Other TCAs (amitriptyline, imipramine, clomipramine, trimipramine) - all have meaningful H1 antagonism contributing to sedation and weight gain, though less than doxepin/mirtazapine

3. Antihistamines used for psychiatric indications (not "antipsychotics" but H1-antagonists used psychiatrically)

  • Hydroxyzine - first-generation H1 antagonist, FDA-approved for anxiety, commonly used off-label for insomnia and agitation
  • Diphenhydramine - used off-label for insomnia and sometimes for acute akathisia/extrapyramidal side effects
  • Promethazine - sedating H1 antagonist occasionally used for agitation/sedation in psychiatric/ED settings

Drugs that are NOT meaningfully H1-active

SSRIs, SNRIs, MAOIs, lithium, benzodiazepines (GABA-A mechanism), and stimulants have little to no clinically relevant H1 antagonism - their sedation, if any, comes from other receptor systems.
Clinical takeaway: H1 antagonism in psychiatric drugs mainly explains sedation and weight gain, not the core therapeutic mechanism (Kaplan & Sadock's Synopsis of Psychiatry, Table 33-2; Stahl's Essential Psychopharmacology). It's a useful axis for predicting which antipsychotic or antidepressant will be more sedating and more likely to cause weight gain.
This is a shared conversation. Sign in to Orris to start your own chat.